KVUE - Total Utang marang Modal Kenvue Health

Logo perusahaan publik Kenvue Inc. (KVUE)

International conflicts are complicating raw material deliveries, triggering asset write-downs in closed regions. However, diversified supply chains for over-the-counter medicines minimize external pressure. Meanwhile, talc-related litigation and high component costs are undermining the financial stability of Kenvue Inc. (KVUE). The balance of debt and equity reflects a debt load where 0.79 represents the latest level.

KVUE: Total Utang marang Modal Kenvue 21.02.2024 - 30.10.2026
Barang utama Kenvue Health

Total debt-to-equity measures the level of financial leverage by comparing total liabilities to the amount of shareholder equity. This metric determines the business's dependence on external borrowings and the associated risks of debt servicing. By analyzing the current debt-to-equity ratio, an investor assesses the stability of the balance sheet. For Kenvue Inc. (KVUE), moderate leverage is justified by the non-cyclical demand for health products. The stable cash flows of this defensive business minimize the risks of high debt.

Analisis pesaing Kenvue Inc.

Utang marang Ekuitas Haleon|Verona Pharma PLC - Utang Agregat marang Ekuitas|Total Utang marang Modal MENS|LGND (Ligand Corp) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal AMRX (Amneal Pharmaceuticals)|Total Utang marang Modal perrigo.com PRGO|ALVO - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi LQDA (Liquidia Corp)|Galapagos Genomics (GLPG) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas ANI Pharmaceuticals Corp|MNKD (MannKind Corporation) - Total Utang marang Modal|Total Utang marang Modal amphastar.com|Rasio Total Utang marang Ekuitas PCRX (Pacira BioSciences, Inc.)|SPRY (ARS Pharmaceuticals Inc) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Theravance TBPH|Aquestive Corp (AQST) - Utang marang Modal|SCPH: Rasio Total Utang marang Ekuitas|Tectonic Therapeutic, Inc. - Utang Agregat marang Modal|TNXP: Total Utang marang Modal|China SXT Pharmaceuticals, Inc. - Rasio Kabeh Utang marang Dana Pribadi|EPRX (Eupraxia Pharmaceuticals, Inc.) - Total Utang marang Modal|Utang marang Modal BioHarvest Sciences Inc BHST|Utang marang Ekuitas eXoZymes Inc (EXOZ)|ORMP (oramed.com) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Entera Bio ENTX|Total Utang marang Modal MindWalk Holdings, Inc. HYFT|ABVC BioPharma Inc - Total Utang marang Modal|Utang marang Modal Cumberland Corp|Quantum BioPharma Ltd (QNTM) - Utang marang Ekuitas|Rasio Utang marang Ekuitas FGEN|Rasio Total Utang marang Ekuitas TELO|Utang marang Ekuitas RANI|Rasio Total Utang marang Ekuitas SNYR (Synergy CHC Corp)|Total Utang marang Modal rallybio.com (RLYB)|Total Utang marang Modal LEXX (Lexaria Bioscience Corp.)|pulmatrix.com (PULM) - Utang marang Modal|PTHL: Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi APM (Aptorum Group Limited)|LYRA: Total Utang marang Modal|IBO - Koefisien Total Utang marang Modal|Utang marang Ekuitas TNF Pharmaceuticals Inc.|Rasio Utang marang Ekuitas YCBD (cbdMD Corp)|Total Utang marang Modal PRFX|Rasio Total Utang marang Ekuitas altamiratherapeutics.com CYTO|Lipella - Rasio Total Utang marang Ekuitas|Koefisien Total Utang marang Modal OptiNose Corp (OPTN)|PIRS - Utang marang Ekuitas|PROC - Total Utang marang Modal|PTPI (Petros Pharmaceuticals, Inc.) - Rasio Total Utang marang Ekuitas|QLI (Qilian International Holding Group) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas SLRN|Total Utang marang Modal TFF Pharmaceuticals, Inc